Therapy for Hepatocellular Carcinoma: Beyond Sorafenib Therapy for Hepatocellular Carcinoma: Beyond Sorafenib
Immunotherapy and protein kinase inhibitors show promise for the treatment of advanced HCC.Chinese Clinical Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
More News: Cancer & Oncology | Carcinoma | China Health | Health | Hematology | Hepatocellular Carcinoma | Immunotherapy | Liver Cancer